%0 Journal Article %A Evgeniya Truntsova %A Dina Bezrukova %T Iodine subsidy as a factor in prevention of bronchial asthma (BA) in infants %D 2011 %J European Respiratory Journal %P p1142 %V 38 %N Suppl 55 %X Object: to evaluate the effectiveness of the prevention of the atopic diseases and BA in babies with the use of the iodine drugs.Methods: Evaluation of the health state of the babies having got the iodine with maternal milk in the lactation period from 3 to 6 months (n=117) were studied. 118 babies without iodine donation was the control group. Evaluation of the health state according to the anamnesis, examination, laboratory data and hereditary predisposition to allergic diseases was carried. The indices of median iodurea in babies were studied.Results: Breast feeding mothers got the potassium iodide at a dose of 200 mcg per day. This dose corresponds with the norms recommended by the WHO for the groups with higher risk of iodine deficiency. Excretion of iodine with urine in babies getting additional iodine in maternal milk was much higher in comparison with the control group (94.6 mcg/L and 38.8 mcg/L respectively; p<0.01). Common number of allergic diseases (atopic dermatitis, bronchial asthma, angioneurotic edema, urticaria, drugs allergy) during the first 3 years of life was evidently lower in the group of babies getting iodine with maternal milk (χ2=3.88; RR=1.77; Sp=0.77). Frequent respiratory infections, especially pneumonia, in the first year of life have a high prognostic coefficient (PK = 7.46 and PK = 8.96, respectively) for the formation bronchial asthma. In basic group it was noted evident decrease of the frequency acute respiratory infections in comparison with the control group (2.9±0.32; 3.7±0.56 respectively, p<0.05).Conclusions: The iodine drugs can be recommended to breast feeding mothers during the lactation period for the prevention atopic diseases and BA in infants. %U